Athersys has been granted a patent for a method to treat cutaneous wounds by administering non-embryonic non-germ cells expressing specific markers without the need for a functionalized substrate. The method aims to promote healing without the risk of transformation or tumorigenesis. GlobalData’s report on Athersys gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Athersys, Human telomerase RT biomarker was a key innovation area identified from patents. Athersys's grant share as of February 2024 was 42%. Grant share is based on the ratio of number of grants to total number of patents.
Method for treating cutaneous burn healing using non-embryonic cells
A recently granted patent (Publication Number: US11918609B2) discloses a method for promoting cutaneous burn healing in a subject by administering specific cells in an effective amount and for a sufficient duration. These cells, referred to as cells (I), are non-embryonic non-germ cells expressing CD90 and either oct4 or telomerase, without being transformed, tumorigenic, or having an abnormal karyotype. The method involves the administration of these cells directly, not from a functionalized substrate, to facilitate the healing process.
Furthermore, the patent claims specify various aspects of the method, including the differentiation potential of the cells into different embryonic lineages, the source of the cells (such as bone marrow or human-derived), the mode of administration (topical, subcutaneous, or injection), and the use of liquid cell suspension or reservoir for delivery. The method also highlights the allogeneic nature of the cells, emphasizing their compatibility for use in human subjects. Overall, the patent provides a detailed framework for utilizing these specific cells to promote cutaneous burn healing effectively.
To know more about GlobalData’s detailed insights on Athersys, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
